About this event

  • Date and time Tue 10 Nov 2020 from 1:00pm to 2:35pm
  • Location Online
  • Organised by Digital Health

Discover how personalised medicine can be used in cancer care.

Hear practical examples of how technology is already being used within the NHS to deliver personalised cancer services. We will discuss tools used in breast cancer care, such as Predict and BOADICEA, and explore how these can be used in primary care. 

Genomics England joins us to offer an overview of developments in personalised medicine across a number of conditions.

Join in the conversation online using #RSMDigiHealth

Follow us on Twitter: @RoySocMed

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted.

This webinar is a part of a series, Personalised Medicine, that will be broadcast weekly on Tuesday afternoons at 1:00pm. If you would like to find out more about the series, please visit the Digital Health Section homepage.

Key speakers

Parker Moss

Chief Commercial & Partnership Officer, Genomics England

Sowmiya Moorthie

Dr Sowmiya Moorthie

Senior Policy Analyst, PHG Foundation

Speaker's biography

Sowmiya is a Senior Policy Analyst at PHG Foundation where she is responsible for the development and delivery projects with an epidemiological and scientific focus. Her interest is in the effective use of scientific knowledge to improve the health of individuals and populations. Sowmiya works with both local and international experts to identify opportunities for health technology implementation and develop policy for science and public health.


Sowmiya has extensive experience in policy development for science and public health in areas including personalised prevention, whole genome sequencing, congenital disorders, newborn screening and prenatal diagnosis. Sowmiya currently leads the Foundation’s work as part of B-CAST, an EU Horizon 2020 project, carrying out research and analysis to examine the capacity development for personalised breast cancer prevention. She also leads their scientific work on polygenic scores.


She is also a research associate with the East of England NIHR Applied Research Collaboration. She works as part of the Population Evidence and Data Science theme contributing to the development, conduct, analysis and implementation of applied population health and care research with a focus on the use of data to improve health.


Sowmiya has a PhD from the University of Cambridge and a Masters in Epidemiology from the London School of Hygiene and Tropical Medicine. She is an associate editor for the Journal of Community Genetics.

Dr Mike Messenger

Independent in-vitro diagnostics (IVD) consultant and visiting professor, University of Leeds

Speaker's biography

Mike has worked in the medical technologies industry for more than 18 years, with a career spanning pharmaceuticals, advanced therapies, medical devices, in-vitro diagnostics (IVDs) and more recently artificial intelligence.


His ambition is to improve human health through the application of safe and effective medical technologies and his research has focused on refining and improving the methods, processes, policies and environment for efficiently progressing devices towards the end goals of market approval and patient benefit.


He is currently a Visiting Professor at the University of Leeds and an independent IVD consultant, providing advice to the IVD industry, the UK Department for Health and Social Care, European Union, National Institute for Health and Care Excellence, NHS England and multiple global diagnostic companies.


He was previously the Head of the Leeds Centre for Personalised Medicine and Health and the Deputy Director
of the National Institute for Health Research (NIHR) In-Vitro Diagnostic Co-Operative in Leeds, with over £30million of research funding, including Cancer Research UK's CANTEST programme, Yorkshire Cancer Research's Lung Screening Trial and the NIHR COVID-19 National DiagnOstic Research and Evaluation Platform (CONDOR).

Jeroen van Duffelen

Mr Jeroen van Duffelen

Chief Operating Officer and Co-Founder, Aidence

Speaker's biography

Mr Jeroen van Duffelen is COO and co-founder of Aidence. Jeroen’s entrepreneurial spirit led him to teach himself software engineering and starting his own company commercializing an online education platform. He then tried his hand in the US startup ecosystem where he joined a rapidly scaling cloud company. Jeroen returned to Amsterdam where he ran a high-tech incubator for academic research institutes, it is here Jeroen first got his taste for applying AI to healthcare. 

In 2015 Jeroen co-founded Aidence, a company developing AI-enabled oncology pathways. At Aidence Jeroen is responsible for the long term strategic direction and business development. In this role, he works closely with key opinion leaders and academics at the forefront of cancer research and clinical care.

Dr Neal Navani

Dr Neal Navani

Consultant Respiratory Physician, University College London Hospital and Associate Professor, University College London

Speaker's biography

Dr Neal Navani qualified in Medicine from Cambridge and UCL in 2000 with distinction and several University prizes. He trained in Respiratory Medicine at the Brompton and Hammersmith Hospitals before winning a Medical Research Council Fellowship in 2008 and completing his PhD at UCL in 2011. He has also completed an MSc in Clinical Trials and Biostatistics at the London School of Hygiene and Tropical Medicine.


Dr Navani is lead clinician for the lung cancer and interventional bronchoscopy services at UCLH, senior clinical of the UK National Lung Cancer Audit and is the respiratory representative on the current NICE lung cancer guideline and quality standards. He also chairs the lung cancer board for North Central and East London Cancer Alliance. He is on the steering group of the British Thoracic Oncology Group.


Dr Navani is also an Associate Professor at UCL. He is a co-applicant on over £3m of grant funding and holds a CRUK grant for the early diagnosis of lung cancer. In August 2019, Dr Navani won a prestigious MRC/NIHR fellowship to research novel predictors of cancer in lung nodules.


View the programme here

Welcome and introduction

Ms Katherine Barbour, Honorary Secretary Digital Health Section, Royal Society of Medicine

A machine learning algorithm to predict risk of cancer in patients referred urgently from primary care

Dr Mike Messenger, Head of Personalised Medicine and Health, Leeds Centre for Personalised Medicine and Health

Personalising breast cancer prevention

Dr Sowmiya Moorthie, Senior Policy Analyst, PHG Foundation

Genomics and personalised cancer medicine

Parker Moss, Chief Commercial and Partnership Officer, Genomics England Ltd

The potential of artificial intelligence to improve early detection and treatment strategies for lung cancer

Mr Jeroen Van Duffelen, Chief Operating Officer and Co-Founder, Aidence and Dr Neal Navani, Lead Clinician, Lung Cancer and Interventional Bronchoscopy Services, University College London Hospitals NHS Foundation Trust

Panel discussion

Chair: Ms Katherine Barbour

Close of meeting



Disclaimer:All views expressed in this webinar are of the speakers themselves and not of the RSM nor the speaker's organisations. 

Special rates for difficult times
The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s weekly COVID-19 Series webinars remain free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic.

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted.

All webinars will be available for registered delegates 30 days after on Zoom. The link will be sent 24 hours after the webinar takes place. 

This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels. 

Personalised medicine webinar series

This series explores the concept of personalised care and the role of digital technology in delivering these services. 

TEp54 Promo
Webinar CPD

Personalised medicine: International perspectives

In the final episode of the series, we examine the international perspectives of personalised care. 

We will discuss approaches to personalised and precision medicine from two of the largest healthcare economies in the world; the USA and China.

Man searching computer

Join the RSM and get unlimited digital learning and e-resources access

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy unlimited digital learning any time you need and access to e-journals, e-books and 6 huge medical databases to support your clinical decision-making and research.

Our e-resources are updated continuously to ensure you receive the cutting edge knowledge you need. 


Become a member